Reimbursement
This is despite seven NextGen ACOs having lost money, and three had dropped out in 2016 due to financial targets they said were set too high to earn savings.
Total costs of Kymriah and 21 similar drugs in development - CAR T-cell therapies - will reach $1 million or more per patient, according to leading cancer experts.
Anthem Technology Center will create new capabilities to enhance the consumer healthcare experience, help improve quality and lower healthcare costs, insurer says.
Insurers have said the move will destabilize the individual market and increase premiums by at least 20 percent.
New CEO Joseph Zubretsky has served top roles at The Hanover Insurance Group and with Aetna.
Overall, 73 percent of Medicare Advantage-PDP enrollees are in plans that have four stars or greater in 2018, CMS says.
For 2018, CMS updated its measures in adjusting three Part C measures for Medicare Advantage only and MA-prescription drug plans.
Physicians object to the policy they say will cause patients to delay seeking treatment and leave bills unpaid.
Smaller physician practices are particularly vulnerable to risk, and there are upfront costs to consider, too.
In addition to the lawsuit, complaints about Medicaid from hospitals, doctors and patients have spiked in Iowa over coverage and payments.